6533b871fe1ef96bd12d1086

RESEARCH PRODUCT

Early and late mortality of spontaneous hemorrhagic transformation of ischemic stroke.

Paolo RagoneseGiorgia FamosoMarco D'amelioGiovanni SavettieriNorma Di BenedettoSabrina RealmutoFrancesca ValentinoPaolo AridonValeria Terruso

subject

Malemedicine.medical_specialtysurvivalBrain IschemiaCohort StudiesHematomaRisk FactorsInternal medicineMedicineHumansStrokeSurvival analysisAgedRetrospective StudiesAged 80 and overIschemic strokeAspirinbusiness.industryProportional hazards modelHeparinMortality rateRehabilitationHazard ratioAnticoagulantsIschemic stroke; epidemiology; hemorrhagic transformation; prognosis; survivalMiddle Agedmedicine.diseaseConfidence intervalSurgeryStrokeSurvival Ratehemorrhagic transformationCardiologyDisease ProgressionepidemiologySettore MED/26 - NeurologiaSurgeryFemaleNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessComplicationIntracranial HemorrhagesprognosiPlatelet Aggregation InhibitorsFollow-Up Studies

description

Background Hemorrhagic transformation (HT), a complication of ischemic stroke (IS), might influence patient's prognosis. Our aim is to evaluate, in a hospital-based series of patients not treated with thrombolysis, the relationship between HT and mortality. Methods We compared mortality of individuals with spontaneous HT with that of individuals without. Medical records of patients diagnosed with anterior IS were retrospectively reviewed. Outcome measures were 30- and 90-day survival after IS onset. Kaplan–Meier estimates were used to construct survival curves. Cox proportional hazards model was used to estimate hazard ratio (HR) for the main outcome measure (death). HT was stratified in hemorrhagic infarction and parenchymal hematoma (PH). We also evaluated the relationship between HT and the main mortality risk factors (gender, age, premorbid status, severity of stroke, and radiological features). Results Thirty days from stroke onset, 8.1% (19 of 233) of patients died. At multivariate analysis, PH (HR: 7.7, 95% confidence interval [CI]: 2.1, 27.8) and low level of consciousness at admission (HR: 5.0, 95% CI: 1.3, 18.6) were significantly associated with death. At 3-month follow-up, mortality rate was 12.1% (28 of 232). At multivariate analysis, large infarct size (HR: 2.7, 95% CI: 1.2, 6.0) and HT (HR: 2.3, 95% CI: 1.0, 5.4) were independent risk factors for mortality. Parenchymal hematoma was, however, the strongest predictor of late mortality (HR: 7.9, 95% CI: 2.9, 21.4). Conclusions Neurological status and infarct size play a significant role, respectively, in early and late mortality after IS. Parenchymal hematoma independently predicts both early and late mortality.

10.1016/j.jstrokecerebrovasdis.2013.06.005https://pubmed.ncbi.nlm.nih.gov/23834850